Key learning from the Dana-Farber Cancer Institute’s 10-year patient safety journey
Conway J, Nathan DG, Benz EJ, et al. “Key Learning from the Dana-Farber Cancer Institute’s 10-Year Patient Safety Journey.” American Society of Clinical Oncology 2006 Educational Book, 42nd Annual Meeting, June 2-6, 2006, in Atlanta, GA. 2006:615-619.
The tragic chemotherapy overdoses to Betsy Lehman and Maureen Bateman, which were discovered at the Dana-Farber Cancer Institute (DFCI) in February 1995, are well known. During the 10-year anniversary of these events, DFCI leadership assessed its patient safety learning, identifying the six most critical elements of learning.
Full text available. Click view article below.
|
This item has not yet been rated
|
 |
View article
|
